Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial (Q44060104)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial |
scientific article |
Statements
1 reference
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial (English)
1 reference
Anthony Lang
1 reference
Stanley Fahn
1 reference
C Warren Olanow
1 reference
Karl Kieburtz
1 reference
Caroline Tanner
1 reference
Parkinson Study Group
1 reference
Ira Shoulson
1 reference
David Oakes
1 reference
Peter LeWitt
1 reference
J William Langston
1 reference
John B Penney
1 reference
Alice Rudolph
1 reference
1 May 2002
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference